- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07623694
Clinical and Functional Effectiveness Assessment of Personalized Management Programs for Patients With Frailty
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
All participants underwent comprehensive geriatric assessment (CGA) and cardiopulmonary exercise testing (CPET). After this the participants will undergo geriatric rehabilitation programs. The participation duration will not exceed 6.5 months including the screening period.
The study comprises three periods:
- screening (1-14 days)
- a treatment course of 3-5 days
- a follow-up period of 6 months On screening visit Study procedures will include
- Informed consent signing
- The Comprehensive Geriatric Assessment (CGA)
- Cardiopulmonary exersize test (CPET)
- The recommendations on a program of geriatric rehabilitation based on CGA and CPET
The inpatient phase will last 3-5 days and will include:
- Implementation of the comprehensive personalized management program
- Issuance of recommendations for continuing the program at the outpatient stage Patients will be randomized into active follow-up and passive follow-up groups based on the number of scheduled telephone contacts using a specially designed structured questionnaire. Active follow-up group: short version of the telephone contact every 1 month during the first three months, with the full version at 3 months. Passive follow-up group: full version of the telephone contact at 3 months. The total duration of the outpatient follow-up phase will be 6 months.
Final visit will be performed at the end of rehabilitation program. It will include:
- The CGA and CPET
- The evaluation of the results of 6 months geriatric rehabilitation program
- The recommendations on a long-term geriatric rehabilitation
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Moscow, Rusland, 129226
- Russian Research and Clinical Center for Gerontology
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
1. Men and women aged 60 and older who wanted to participate in the study and signed a consent form.
Exclusion Criteria:
- Presence of acute diseases or exacerbation of chronic diseases within 2 weeks prior to study inclusion.
- Presence of active malignant oncological diseases.
- Presence of severe cognitive impairment (dementia) and sensory deficits that may affect the ability to perform or evaluate study procedures.
- Presence of anemia (hemoglobin level <110 g/L).
- Presence of musculoskeletal disorders or peripheral artery disease that may affect mobility and the ability to undergo study procedures.
- Presence of one or more contraindications to exercise testing.
- Any other condition that, in the investigator's opinion, may preclude the patient's participation in the study.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Frailty
Frail subjects of 60 years and older will get geriatric rehabilitation program based on CGA and CPET
|
Geriatric rehabilitation program based on CGA and CPET will be performed under physicians' tight control over 3-5 days, followed by outpatient continuation for 6 months.
After 6 months, CGA and CPET will be repeated to evaluate program effectiveness.
|
|
Experimenteel: Prefrailty
Pre-Frail subjects of 60 years and older will get geriatric rehabilitation program based on CGA and CPET
|
Geriatric rehabilitation program based on CGA and CPET will be performed under physicians' tight control over 3-5 days, followed by outpatient continuation for 6 months.
After 6 months, CGA and CPET will be repeated to evaluate program effectiveness.
|
|
Experimenteel: Robust
Non-frail Frail subjects of 60 years and older will get geriatric rehabilitation program based on CGA and CPET
|
Geriatric rehabilitation program based on CGA and CPET will be performed under physicians' tight control over 3-5 days, followed by outpatient continuation for 6 months.
After 6 months, CGA and CPET will be repeated to evaluate program effectiveness.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
functional status dynamics
Tijdsspanne: 6 months
|
Instrumental and Basic Activity Daily Life scale score
|
6 months
|
|
Change in aerobic exercise capacity
Tijdsspanne: 6 months
|
eak oxygen uptake (VO₂ peak) measured during cardiopulmonary exercise testing (CPET)
|
6 months
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Olga N Tkacheva, Dr., Pirogov Russian National Research Medical University, the Russian Research and Clinical Center for Gerontology
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Neurologische manifestaties
- Ziekten van het zenuwstelsel
- Neuromusculaire manifestaties
- Pathologische processen
- Pathologische aandoeningen, anatomisch
- Spieratrofie
- Atrofie
- Pathologische aandoeningen, tekenen en symptomen
- Tekenen en symptomen
- Kwetsbaarheid
- Sarcopenie
- Clostridium perfringens epsilon-toxine
Andere studie-ID-nummers
- CPET/GR
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .